Teladoc Health Inc [TDOC] stock is trading at $9.25, up 0.22%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TDOC shares have lost -0.64% over the last week, with a monthly amount drifted -5.13%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Teladoc Health Inc [NYSE: TDOC] stock has seen the most recent analyst activity on February 29, 2024, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $22. Previously, Leerink Partners started tracking the stock with Market Perform rating on February 26, 2024, and set its price target to $17. On January 17, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $22 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $26 on January 03, 2024. Stephens initiated its recommendation with a Equal-Weight and recommended $25 as its price target on April 12, 2023. SVB Securities upgraded its rating to Outperform for this stock on February 23, 2023, but kept the price target unchanged to $34. In a note dated October 24, 2022, Guggenheim upgraded an Neutral rating on this stock.
Teladoc Health Inc [TDOC] stock has fluctuated between $8.73 and $30.41 over the past year. Currently, Wall Street analysts expect the stock to reach $53.96 within the next 12 months. Teladoc Health Inc [NYSE: TDOC] shares were valued at $9.25 at the most recent close of the market. An investor can expect a potential return of 483.35% based on the average TDOC price forecast.
Analyzing the TDOC fundamentals
Teladoc Health Inc [NYSE:TDOC] reported sales of 2.62B for the trailing twelve months, which represents a growth of 2.68%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.1 and Total Capital is -0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.01 points at the first support level, and at 8.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.56, and for the 2nd resistance point, it is at 9.88.
Ratios To Look Out For
For context, Teladoc Health Inc’s Current Ratio is 3.73. Further, the Quick Ratio stands at 3.65, while the Cash Ratio is 2.82. Considering the valuation of this stock, the price to sales ratio is 0.60, the price to book ratio is 0.68.
Transactions by insiders
Recent insider trading involved Nanis Nikolaos P., Chief Technology Officer, that happened on Jul 02 ’24 when 442.0 shares were sold. CHIEF MEDICAL OFFICER, Raman-Tangella Vidya completed a deal on Jun 04 ’24 to sell 468.0 shares. Meanwhile, ACTING CEO, CFO Murthy Mala sold 8807.0 shares on Jun 03 ’24.
